Product Description
Technical Specification
- Minimum Order Quantity : 1 Vial
- Packaging Size : Vial
- Storage : 2-8
- Prescription/Non prescription : Prescription
- Packaging : vial
- Treatment : anti caner
- Brand : bryxta 100 Mg Injection
- Composition : Bevacizumab
- Manufacturer : zydus
Advanced Cancer Therapy for Optimal ResultsBryxtra 100mg Injection is specifically engineered for patients undergoing treatment for chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Designed as part of a hospital-based therapeutic regimen, Bryxtra offers modern efficacy and dependable safety standards guided by Indian regulatory requirements. Its use of aseptic manufacturing and GMP practices assures both practitioners and patients of its reliability in clinical oncology.
Careful Preparation and AdministrationThis injection is supplied as a lyophilized powder that requires reconstitution with sterile water for injection, resulting in a clear, colorless to slightly yellow solution. Intended strictly for intravenous use, administration should only be performed by qualified healthcare professionals to ensure appropriate dosing and patient safety. Compatibility with conventional IV equipment further streamlines its use in a hospital environment.
FAQ's of Bryxtra 100mg Injection:
Q: How should Bryxtra 100mg Injection be administered?
A: Bryxtra 100mg Injection must be administered intravenously after reconstituting the vial with sterile water for injection. It is strictly for hospital use and should only be given by qualified healthcare professionals according to physician instructions.
Q: What are the main therapeutic indications for Bryxtra 100mg Injection?
A: Bryxtra 100mg Injection is primarily indicated for the treatment of chronic lymphocytic leukemia and non-Hodgkin's lymphoma as part of anticancer therapy protocols.
Q: When should Bryxtra 100mg Injection not be used?
A: Do not use Bryxtra 100mg Injection after the expiry date noted on the pack. Additionally, it should not be administered to individuals with hypersensitivity to Bendamustine or other vial components, unless directed by a healthcare professional.
Q: Where should Bryxtra 100mg Injection be stored?
A: Store Bryxtra 100mg Injection in a dry, cool place, protected from sunlight and moisture, ensuring it remains within its specified shelf life of 24 months for maximum efficacy and safety.
Q: What is the process for preparing Bryxtra 100mg Injection for use?
A: To prepare Bryxtra 100mg Injection, reconstitute the lyophilized powder in the vial with sterile water for injection as per the instructions provided. The resulting solution should be clear and either colorless or slightly yellow in appearance.
Q: What is the benefit of Bryxtra's manufacturing process?
A: Bryxtra 100mg Injection is manufactured aseptically under stringent GMP guidelines, ensuring a high-grade, contaminant-free product that meets Indian regulatory approval for safety and effectiveness.
Q: What should I do if the solution develops an unusual appearance or smell upon reconstitution?
A: If Bryxtra 100mg Injection, after reconstitution, shows any discoloration, particulate matter, or an unusual smell beyond the slight fermentation odor expected, do not use the solution and contact the supplying pharmacist or healthcare provider immediately.